Swedish radiation therapy firm Elekta has received Food and Drug Administration 510(k) clearance for its Synergy radiation therapy platform. The product uses x-ray volume imaging technology that is integrated directly onto the treatment system.
Synergy allows pre-treatment tumor imaging to be performed immediately prior to treatment, decreasing the risk that a tumor or internal organs will change position, according to the Stockholm-based company. In addition, because the patient doesn't have to be moved from an imaging device to the radiotherapy treatment machine, the problem of errors from patient re-setup are eliminated.
Synergy received the European CE Mark in July 2003.
By AuntMinnie.com staff writersOctober 28, 2003
Related Reading
Siemens, Elekta sign distribution accord, October 22, 2003
Elekta signs HPG deal, September 11, 2003
Elekta licenses Axeda DRM product, September 2, 2003
Elekta inks MedAssets deal, November 14, 2002
Elekta IMRT planner gets 510 (k) clearance, October 9, 2002
Copyright © 2003 AuntMinnie.com
